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a b s t r a c t
Flow-perfusion is being promoted as a way to grow tissue-engineered cartilage in vitro. Yet, there is a
concern that ﬂow-perfusion may induce unwanted mechanical effects on chondrogenesis and terminal
differentiation. Therefore, the aim of this study is to evaluate the effect of ﬂuid ﬂow on chondrogenesis
and chondrocyte hypertrophy of MSCs in a well-established pellet culture model.
Human MSC pellets were mounted into 3D-printed porous scaffolds in basic chondrogenic
differentiation medium, containing TGF-β2. Constructs were then allowed to form cartilaginous matrix
for 18 days, before they were transferred to a custom-built ﬂow-perfusion system. A continuous ﬂow of
1.22 ml min1 was applied to the constructs for 10 days. Controls were maintained under static culture
conditions. To evaluate chondrogenic and hypertrophic differentiation, RNA was isolated at day 20 and
28 and histology, immunohistochemistry and western blot analyses were performed after 28 days of
culture.
Abundant matrix was formed in the constructs, but production of chondrogenic and hypertrophic
matrix components was affected by ﬂow-perfusion. Although gene expression levels of the (late)
hypertrophic and osteogenic marker osteocalcin increased by ﬂow-perfusion, this did not result in more
collagen type X protein deposition. Decreased GAG release, in combination with diminished collagen II
staining, indicates reduced chondrogenesis in response to ﬂow-perfusion.
Caution should thus be taken when applying ﬂow-perfusion to cultures to improve nutrient diffusion.
Although we show that it is possible to inﬂuence the differentiation of chondrogenic differentiated MSCs
by ﬂow-perfusion, effects are inconsistent and strongly donor-dependent.
& 2013 Elsevier Ltd. All rights reserved.
1. Introduction
Articular cartilage is an avascular, low-friction, and wear-
resistant weight-bearing tissue, which has a limited self-renewal
capacity once it is damaged. Therefore, cartilage tissue engineering
approaches have been introduced involving chondrocytes or
mesenchymal stem cells (MSCs) embedded in a support material
which are stimulated mechanically or chemically, to create a
functional tissue replacement (Kock et al., 2012; Gardner et al.,
2013; Huey et al., 2012).
It is generally known that MSCs can undergo in vitro chondro-
genic differentiation in the presence of appropriate stimuli
(Puetzer et al., 2010; Johnstone and Yoo, 1999; Johnstone et al.,
1998). The advantage of using MSCs in cartilage tissue engineering
studies is that they have an extensive proliferation capacity, while
maintaining their differentiation properties and they can be
obtained in a less invasive manner than chondrocytes. Differentia-
tion of MSCs into the chondrogenic lineage is a complex process,
which is largely donor dependent (Gawlitta et al., 2012; Meyer
et al., 2011). While clinical studies employing MSCs for treatment
of cartilage defects are still in their infancy, MSCs hold great
promise for future production of cartilaginous constructs. A major
disadvantage of MSCs is that they exhibit a hypertrophic tendency
when differentiated into the chondrogenic lineage. This can result
in calciﬁcation of ectopically transplanted neocartilage matrix as
was demonstrated in mouse models in vivo (Pelttari et al., 2006;
Jukes et al., 2008). Thus, methods to better understand and control
this unwanted hypertrophic differentiation are required (Zhang
et al., 2012).
Mechanical cues are believed to inﬂuence hypertrophic differ-
entiation of chondrocytes and MSCs in vitro, since growth plate
and articular hypertrophy in vivo are regulated by mechanical
loading (van Donkelaar and Huiskes, 2007). Different types of
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/jbiomech
www.JBiomech.com
Journal of Biomechanics
0021-9290/$ - see front matter & 2013 Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.jbiomech.2013.11.006
n Correspondence to: Department of Orthopaedics, University Medical Center
Utrecht, PO Box 85500, G05.228, 3508 GA Utrecht, The Netherlands.
Tel.: þ31 88 755 8035; fax: þ31 30 251 0638.
E-mail address: d.gawlitta@umcutrecht.nl (D. Gawlitta).
Journal of Biomechanics 47 (2014) 2122–2129
mechanical loading have been predicted to inﬂuence chondrogenic
and hypertrophic differentiation of chondrocytes (van Donkelaar
and Wilson, 2012). Cyclic tension, for example, induces expression
of terminal hypertrophic differentiation markers in chondrocytes
in vitro (Wong et al., 2003; Yang et al., 2006; Beaupre et al., 2000;
Wu and Chen, 2000). In contrast, dynamic compressive loading
enhances cartilage matrix synthesis and distribution and sup-
presses the expression of major hypertrophic genes and matrix
mineralization in MSC-laden hyaluronic acid hydrogels (Bian et al.,
2012).
Flow perfusion is being promoted as a way to grow both tissue
engineered cartilage and bone in vitro (Yeatts and Fisher, 2011;
Schulz and Bader, 2007). Culturing chondrocytes under direct ﬂow
perfusion has been shown to stimulate proliferation and accumu-
lation of cartilage markers (Beaupre et al., 2000; Pazzano et al.,
2000; Freyria et al., 2005). However, ﬂuid ﬂow induces shear
stress that may induce unwanted mechanical effects on chondro-
genesis and terminal differentiation (Stevens et al., 1999; Carter
and Wong, 2003; Garzon-Alvarado et al., 2011). A more thorough
investigation of the effect of ﬂuid ﬂow on chondrogenic MSC
differentiation is necessary to diminish potentially harmful effects
of ﬂow-perfusion in cartilage tissue engineering studies. Further-
more, these insights can be used to improve the development of
bioreactors that give an optimal yield of cartilaginous tissue in a
tissue engineering setting. Therefore, the aim of this study is to
evaluate the effect of ﬂow-perfusion on chondrogenic hypertrophy
of MSCs in a well-established pellet culture model (Schon and
Schrobback, 2012).
2. Methods
2.1. Preparation of PCL scaffolds
Polycaprolactone (PCL, Sigma) was printed (27G needle, 200 mm/min speed,
200 rpm spindle speed) into 22 cm layered, porous 3D square lattice-work
constructs with a height of 3.75 mm and a ﬁber spacing of 1.05 mm (Fig. 2).
Scaffolds were cut into 55 mm pieces, sterilized in 70% ethanol and air-dried in a
laminar airﬂow cabinet. Before cell pellets were inserted (Schon and Schrobback,
2012; Schuurman et al., 2013), scaffolds were incubated with MSC expansion
medium without rhB-FGF2 (αMEM (22561, Minimum Essential Medium α; Invitro-
gen) containing 10% fetal bovine serum (DE14-801F; BioWhittaker), 0.2 mM
L-ascorbic acid 2-phosphate (A8960; Sigma), and 100 U/ml penicillin with
100 mg/ml streptomycin (PenStrep; Invitrogen)).
2.2. Flow-perfusion bioreactor system
The ﬂow-perfusion bioreactor system consists of a custom-built polycarbonate
ﬂow chamber, a peristaltic continuous ﬂow pump (7519-15; Masterﬂex L/S™) and a
spinner ﬂask as medium reservoir (Fig. 1). Protrusions of 0.5 mm from the ﬂow
chamber wall prevented the scaffold from moving. The construction was connected
with ﬂexible tubes using Luer locks (Fig. 1).
2.3. Isolation of Human MSCs
Human MSCs were isolated from bone marrow biopsies out of the iliac crest
after obtaining written informed consent (Medical Ethical Committee, University
Medical Center Utrecht) of patients undergoing hip replacement surgery (donor A:
male, 56 years; donor B: male, 63 years; donor C: female, 32 years). Cells were
harvested at passages 2–4 for pellet formation. After expansion, the MSCs were
characterized as described previously (Gawlitta et al., 2012). The complete experi-
ment was performed 3 times with MSCs from the individual donors.
2.4. Pellet culture system
MSCs were centrifuged in 96-well plates (7007; Corning) at 300 g for 5 min to
form cell pellets of 250,000 cells each (n¼96 per donor). Pellets were subsequently
cultured in chondrogenic differentiation medium (CDM) containing high glucose
Dulbecco's modiﬁed Eagle's medium (DMEM 31966; Invitrogen) with 1% ITSþ
premix (354352; BD Bioscienes), 107 M dexamethasone (D8893; Sigma), 0.2 mM
L-ascorbic acid 2-phosphate (A8960; Sigma), PenStrep, and 10 ng/ml TGFβ2 (302-
B2; R&D Systems) for 7 days. The CDM was refreshed at least twice weekly.
Fig. 1. Schematic representation of the ﬂow-perfusion bioreactor system, consisting of a custom-built polycarbonate ﬂow chamber, a peristaltic continuous ﬂow pump and a
spinner ﬂask as medium reservoir.
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2.5. Experimental set-up
After 7 days, 8 pellets per scaffold were transferred into 8 separate pores of 12
separate PCL scaffolds (geometry shown in Fig. 2) with small sterile spoons and
cultured in 24-wells plates in CDM that was replaced twice weekly. At day 18, half
of the constructs (n¼6) were placed into the ﬂow chambers with sterile tweezers
(Fig. 1). Cell pellets were located at the side of medium inﬂow in such a way that
pellets were facing the medium ﬂow (Fig. 1). To prevent dehydration, 1 ml of
CDM was added to each scaffold in the ﬂow chamber before closing it. After covers
were secured, ﬂow chambers were placed upright and connected to the medium
reservoir, containing 9 ml of CDM. Medium was pumped around to check for
leakages before the assembly was transferred to an incubator (37 1C and 5% CO2).
A continuous ﬂow of 1.22 ml min1 was applied for 10 days. Controls (n¼6) were
maintained in a 6-well plate with 1 sample and 10 ml CDM per well. Medium was
not refreshed during these 10 days. At day 20, 1 construct per group was harvested
for quantitative real-time polymerase chain reaction (qPCR).
2.6. Histology and immunohistochemistry
Pellet-containing constructs (n¼2 per group) were ﬁxed in 10% formalin,
embedded in parafﬁn and subsequently 5 mm sections were cut. Before (immuno)
histological stainings were performed, sections were deparafﬁnized and rehy-
drated. After staining, sections were dehydrated, mounted in depex and evaluated
with light microscopy (Olympus).
2.6.1. Safranin-O staining
Sections were stained with Weigert's hematoxylin (640490; Klinipath BV) for
5 min and 0.4% fast green (1.04022.0025; Merck) for 4 min. After rinsing in 1%
acetic acid, they were stained with 0.125% Safranin-O (1.15948.0025, Merck) for
5 min.
2.6.2. Von Kossa staining
Sections were rinsed with distilled water and then incubated at room temper-
ature in 1% silver nitrate (5/1240/46; Thermo Fisher) solution directly under a light
bulb for 1 h. Sections were subsequently washed with 5% sodium thiosulphate
(A17629; Alta Aesar) and counterstained with hematoxylin.
2.6.3. Collagen types II and X
Immunohistochemical detection of collagen types II and X was performed as
described in detail previously (Gawlitta et al., 2012).
2.7. Quantitative real-time polymerase chain reaction (qPCR)
RNA was extracted from the pellets of 1 construct at day 20 and 2 constructs at
day 28 of each donor and treated with 10 TURBO™ DNase (Ambion). Subse-
quently, cDNA was synthesized by using the iScriptTM cDNA Synthesis kit (Bio-
Rad). qPCR was performed by applying iQ SYBR Green Supermix (Cat. No. 170-8885;
Bio-Rad) on a MyIQ PCR system (Bio-Rad). Gene expression patterns were
determined for GAPDH, alkaline phosphatase (ALPL), osteocalcin (BGLAP) and
collagen types II (COL2A1) and X (COL10A1) (Table 1). The Ct values of the target
genes were corrected for GAPDH expression levels. Data are represented as fold
induction of genes of interest for ﬂow-perfusion conditions versus static conditions
using the delta-delta Ct method.
2.8. GAG release
GAG release in the culture medium from days 18 to 28 was determined
spectrophotometrically after reaction with dimethylmethylene blue dye (DMMB,
Sigma) by measuring absorbances at 540 and 595 nm, using a chondroitin sulfate C
standard (Sigma-Aldrich).
2.9. Collagen type X quantiﬁcation
Protein was extracted overnight from pellets of 1 construct per donor at 4 1C in
lysis buffer, containing 0.05 M Tris–HCl, 5 mM EDTA, 1 mM N-ethylmaleimide,
1 mM phenylmethanesulphonyl ﬂuoride and 0.1% SDS. Extracts were centrifuged
for 10 min at 10,600 g at 4 1C and supernatant was stored at 20 1C. Protein was
separated on a 8% polyacrylamide gel, followed by transfer to a polyvinylidene
ﬂuoride membrane (Millipore) by electroblotting. Membranes were blocked for
non-speciﬁc binding in Odysseys Blocking Buffer (927-40000; LI-COR) followed by
incubation with a 1:500 diluted murine anti-collagen type X antibody (X53;
Quartett) and a 1:400 diluted anti-β-actin antibody (130656, Santa Cruz) overnight
at 4 1C. After washing of the membranes, blots were incubated with an anti-mouse
biotinylated IgG (1:400; RPN1001V; GE Healthcare) for collagen type X detection.
Finally, membranes were incubated with streptavidin Dylight 800 conjugated
(1:10.000, Thermo Fisher) for collagen type X and goat anti-rabbit IgG Dylight
680 (1:10.000, Thermo Fisher) for β-actin. Signals were visualized and quantiﬁed by
an Odysseys Infrared Imaging System (LI-COR).
2.10. Statistical analysis
All data are presented as means7standard deviation. For evaluation of gene
expression levels, effects of the independent variables treatment and time as well
as their interaction were examined for signiﬁcant differences by two-way analysis
of variance (ANOVA) in SPSS. If no signiﬁcant interaction was found, a one-way
ANOVA with Bonferroni post-hoc testing was used to search for signiﬁcant diffe-
rences within the other factor level. In case of signiﬁcant interaction, an indepen-
dent t-test with Bonferroni correction for a number of speciﬁc comparisons was
used to test for signiﬁcant differences. Signiﬁcant differences in GAG release
between static and perfused constructs were determined with a one-way ANOVA
with Bonferroni post-hoc testing.
Fig. 2. Overview and timeline of experimental set-up. At day 0 pellets were created and after 7 days of culture in CDM they were transferred to the scaffold. At day 18, half of
the scaffolds (n¼6) was transferred to the ﬂow-perfusion bioreactor system, while the other half served as static culture controls. At day 20, 1 construct per group was
harvested for qPCR. The remaining constructs were harvested at day 28 for qPCR, histology, immunohistochemistry and quantiﬁcation of collagen type X.
Table 1
Primer sequences for the human genes that were used in the polymerase chain
reaction analyses. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; COL,
collagen; BGLAP, osteocalcin; ALPL, alkaline phosphatase.
Gene Forward primer sequence (3′-5′) Reverse primer sequence (3′-5′)
GAPDH ATGGGGAAGGTGAAGGTCG TAAAAGCAGCCCTGGTGACC
COL2a1 AGGGCCAGGATGTCCGGCA GGGTCCCAGGTTCTCCATCT
COL10a1 CACTACCCAACACCAAGACA CTGGTTTCCCTACAGCTGAT
ALPL CCAAAGGCTTCTTCTTGCTG CCACCAAATGTGAAGACGTG
BGLAP CGCAGCCACCGAGACACCAT GGGCAAGGGCAAGGGGAAGA
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3. Results
3.1. Macroscopic appearance of scaffolds and MSC pellets at day 28
The MSCs of all 3 human donors successfully formed spherical
aggregates during the ﬁrst 2 weeks of culture and aggregates
remained in the PCL mesh for the remaining culture period. Pellets
of donors B and C demonstrated a similar spherical appearance
and single aggregates could be distinguished. Pellets of donor A
were larger and had fused together within the pores in some cases
(Fig. 3). In general, pellets of static cultures appeared to be larger
compared to pellets cultured under perfusion.
3.2. Histology and immunohistochemistry
Intensity of Safranin-O staining on cultures of donor A was very
homogeneous and no obvious differences between static and
perfused samples were observed (Fig. 4a). Heterogeneous and less
intense staining was seen in cultures from donors B and C. The
presence of ﬂow-perfusion resulted in absence of GAG deposition
in samples of donor B and in reduced localized deposition of GAGs
in the periphery of pellets from donor C. Collagen type II
immunostaining conﬁrmed the results of the Safranin-O staining,
except for donor A (Fig. 4b). Deposition of collagen type II in
pellets from donor A was less homogenous and mostly located in
the periphery as compared to proteoglycan deposition in pellets
from the same donor. In cell pellets from donor B and C, collagen
type II deposition was reduced in perfused samples and contained
only local areas with collagen type II. Hypertrophic differentiation
was evaluated with collagen type X immunohistochemistry and
Von Kossa staining. Von Kossa staining was not observed in any of
the cultures (data not shown), indicating absence of mineraliza-
tion. In contrast, collagen type X was detected locally in most of
the constructs and appeared primarily in the periphery of the
pellets (Fig. 5). Although differences were not very clear, collagen
type X staining appeared to be more pronounced in static cultures.
Notably, cell morphology in these areas did not resemble the
typical hypertrophic geometry in large lacunae.
3.3. Expression of chondrogenic and hypertrophic genes
Collagen type II expression was decreased signiﬁcantly in
ﬂow-perfusion versus static cultures at day 28 (Fig. 6). In general,
genes of (early) hypertrophic markers ALP and collagen type X
were expressed at similar or lower levels in the ﬂow-perfusion
cultures compared with their static counterparts, albeit not
statistically signiﬁcant. In contrast, gene expression of osteocalcin
was increased in ﬂow-perfusion cultures at day 28 compared to
static controls.
3.4. GAG release in culture medium
Fewer GAGs were detected in the culture medium of perfused
constructs of donor A en C, compared to static controls (only
signiﬁcant for donor C) (Fig. 7). In culture medium of donor B,
an overall lower release of GAGs was detected and no diffe-
rences between control and ﬂow-perfusion were observed. These
results conﬁrm the reduced chondrogenic potential, shown by
gene expression levels, of constructs that were subjected to ﬂow-
perfusion.
3.5. Collagen X quantiﬁcation
Production of collagen type X differed between donors (Fig. 8).
Statically cultured constructs of donor A and C contained clearly
more collagen type X, compared to the perfused constructs.
However, absolute amounts of collagen type X in samples of donor
A were almost one order of magnitude higher than in constructs of
donor C. For donor B, no obvious differences between perfused
and static constructs were observed.
Fig. 3. Overview of gross macroscopic appearance of MSC pellets from 3 different donors in PCL scaffolds at day 28 of static (upper row) and perfused (lower row) constructs.
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4. Discussion
Flow-perfusion caused decreased production of chondrogenic
and hypertrophic matrix components. Although gene expression
levels of the (late) hypertrophic and osteogenic marker osteocalcin
increased by ﬂow-perfusion, this did not result in more collagen
type X protein deposition. Decreased GAG release, in combination
with diminished GAG and collagen II staining, indicates reduced
chondrogenesis in response to ﬂow-perfusion.
4.1. Flow-perfusion and chondrogenic hypertrophy
Gene expression levels of osteocalcin, a late hypertrophic
marker, were signiﬁcantly elevated after 10 days of ﬂow perfusion
compared to the static control. We hypothesize that a cartilage
mold was created during the ﬁrst 18 days of culture in chondro-
genic medium and that increased osteocalcin gene expression
levels in response to ﬂow-perfusion indicate the onset of hyper-
trophic differentiation. However, no signiﬁcant effect of ﬂow-
perfusion on collagen type X or ALP gene expression levels
was observed, although the latter seemed to be increased at
day 28, albeit not statistically signiﬁcant. Surprisingly, increased
osteocalcin gene expression levels did not translate into more
collagen type X protein deposition after 28 days of culture.
Although differences were not very clear, collagen type X staining
appeared to be more pronounces in static cultures. Interestingly,
cell morphology in these areas did not resemble the typical
hypertrophic geometry in large lacunae. The elevated levels
of osteocalcin could also have indicated differentiation towards
the osteogenic lineage (Yu et al., 2012; Gardel et al., 2013).
It is possible that there were still undifferentiated MSCs pre-
sent in the pellets after 18 days of chondrogenic culture, which
were subsequently forced into the osteogenic pathway by ﬂow-
perfusion.
Fig. 4. Chondrogenic differentiation of MSC pellets, isolated from 3 human donors (A–C) and cultured under static or ﬂow-perfusion conditions. (a) Safranin-O/fast green-
stained parafﬁn sections reveal the presence of proteoglycans (red). (b) Immunohistochemical detection of collagen type II (brown) in the sections. Scale bars in (a) denote
200 mm and in (b) 500 mm. (For interpretation of the references to color in this ﬁgure caption, the reader is referred to the web version of this article.)
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4.2. Flow-perfusion and chondrogenesis
Collagen type II gene expression levels were decreased in ﬂow-
perfused cultures. Safranin-O staining conﬁrms the diminished chon-
drogenic potential of MSCs that were exposed to ﬂow-perfusion.
Interestingly, previous studies demonstrated increased gene expres-
sion levels of collagen type II by goat bone marrow cells (Goncalves
et al., 2011) and enhanced anabolic and catabolic responses by human
articular chondrocytes (Grogan et al., 2012) and porcine chondrocytes
(Tran et al., 2011) in response to a ﬂow rate of 0.1 ml min1. The ﬂow
rate of 1.22 ml min1 used in the present study is more than 10 times
higher compared to aforementioned studies, which may explain the
differential effects. This could be in agreement with the hypothesis
that exposure of chondrocytes to low shear stress maintains chon-
drogenesis, whereas high shear stress induces hypertrophy (Stevens
et al., 1999; Carter and Wong, 2003). However, exact amounts
of shear stress applied are unknown and modeling of computational
shear stress may be necessary to optimize ﬂow-perfusion culture
conditions.
4.3. Flow perfusion and distribution of matrix components
Limited mass transport may be a reason for the heterogeneous
tissue distribution due to the characteristic ﬂuid-ﬂow environment
that is created (Lappa, 2003; Radisic et al., 2006). During the 18 days
of culture in chondrogenic medium prior to ﬂow-perfusion, cells will
have deposited abundant extracellular matrix components, which
may have limited ﬂuid ﬂow and consequently nutrient supply within
the pellets. One could hypothesize that application of ﬂow-perfusion
would stimulate a more homogenous tissue distribution. However,
Fig. 5. Immunohistochemical detection of collagen type X (brown) in sections of MSC pellets, isolated from 3 different human donors (A–C) and cultured under static or
ﬂow-perfusion conditions. (For interpretation of the references to color in this ﬁgure caption, the reader is referred to the web version of this article.)
Fig. 6. The fold change of gene expression in perfused versus static cultures,
normalized to housekeeping gene GAPDH at 20 and 28 days. GAPDH, glyceralde-
hyde 3-phosphate dehydrogenase; COL2a1, collagen type II; COL10a1, collagen type
X; BGLAP, osteocalcin; ALPL, alkaline phosphatase. npo0.05 versus static culture at
the same time point.
Fig. 7. GAG released per construct in culture medium in static and ﬂow-perfused
constructs at day 28, after 10 days of bioreactor culture. ♯po0.05 versus static
culture of donor B and npo0.05 versus static culture of the same donor.
Fig. 8. The amount of collagen type X protein present in constructs cultured under
static and ﬂow-perfusion conditions after 28 days of culture.
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the opposite was observed in our study (except for constructs of
donor A), with cartilage deposition mostly in the periphery of ﬂow-
perfused constructs and more distributed matrix under static condi-
tions. We suspect that the cell-tissue aggregates were very dense
with low porosity, and ﬂow-perfusion will therefore have predomi-
nantly caused shear stress at the outside of the aggregates instead of
improving diffusion within the pellet cultures, which could also
explain effects observed mostly at the periphery of perfused cultures.
4.4. Donor-dependent variations strongly inﬂuence treatment-
dependent effects
Since inter-donor variations were mostly larger than inter-
experimental differences, it is impossible to pinpoint the effect of
ﬂow-perfusion. Heterogeneity of MSCs is a well-known phenom-
enon that can explain success or failure of tissue regeneration
(Siegel et al., 2013; Torensma et al., 2013). It was shown before that
there are donor-dependent differences in MSC differentiation
toward chondrogenic and hypertrophic phenotypes (Farrell et al.,
2009; Gawlitta et al., 2012). Also, it was demonstrated that the
isolation site of MSCs can affect the chondrogenic potential of the
derived cells (Sakaguchi et al., 2005) and that tissue source has a
greater inﬂuence on gene expression proﬁles than different culture
methods (Torensma et al., 2013). To minimize variations due to
site-speciﬁc characteristics, MSCs used in the present study were
isolated from human bone marrow from the iliac crest. These and
previously obtained results stress the necessity for a screening
method to select MSCs with properties most suitable for their
application.
5. Conclusion
In conclusion, our ﬁndings indicate that caution should be taken
when applying ﬂow-perfusion to cultures to improve nutrient diffu-
sion. Although we show that it is possible to inﬂuence the differentia-
tion of chondrogenic differentiated MSCs by ﬂow-perfusion, effects are
inconsistent and strongly donor-dependent.
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